|Bid||30.42 x 300|
|Ask||30.44 x 10000|
|Day's Range||30.37 - 30.52|
|52 Week Range||25.19 - 30.68|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.34%|
In Russia, Teva Pharmaceutical has created a strong portfolio of about 300 products and has been extensively developing its research pipeline.
Teva Pharmaceutical (TEVA) currently operates in three types of markets in the European Union.
Excluding API sales, in 2016, Teva Pharmaceutical Industries is expected to earn about 50% of its net sales from the North American market.